INTERSTITIAL LUNG ABNORMALITIES

Clinical trials for INTERSTITIAL LUNG ABNORMALITIES explained in plain language.

Never miss a new study

Get alerted when new INTERSTITIAL LUNG ABNORMALITIES trials appear

Sign up with your email to follow new studies for INTERSTITIAL LUNG ABNORMALITIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Race to stop lung scarring before it starts in High-Risk families

Prevention Recruiting now

This study is testing whether a drug called nerandomilast can prevent or slow down lung scarring in people who are at high risk because they have a family history of pulmonary fibrosis and early signs of lung changes on a scan. Participants, who are 40 or older, will take either …

Matched conditions: INTERSTITIAL LUNG ABNORMALITIES

Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Prevention

Last updated Mar 30, 2026 14:33 UTC

INTERSTITIAL LUNG ABNORMALITIES

Get alerted when new INTERSTITIAL LUNG ABNORMALITIES trials appear

Race to stop lung scarring before it starts in High-Risk families